$5,590,000
Income reported
26
Clients represented
131
Filings counted
0
Former members lobbying
Clients
26
- ASTRAZENECA PHARMACEUTICALS LP $480,000
- GILEAD SCIENCES, INC. $360,000
- INCYTE CORPORATION $360,000
- JUUL LABS INC $360,000
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA $360,000
- ABBOTT LABORATORIES $300,000
- ABBVIE INC. $300,000
- MERCK & CO., INC. $300,000
- OTSUKA AMERICA PHARMACEUTICAL, INC. $300,000
- PHLOW CORP. $300,000
- SANOFI U.S. SERVICES, INC. $300,000
- CALIFORNIA LIFE SCIENCES $240,000
- GLAXOSMITHKLINE $240,000
- MEDTRONIC, INC. $240,000
- SUPERNUS PHARMACEUTICALS FKA SAGE THERAPEUTICS $200,000
- DELFI DIAGNOSTICS $180,000
- UNITED SERVICES AUTOMOBILE ASSOCIATION (USAA) $180,000
- ELEVATEBIO $140,000
- PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICAL $140,000
- IPSEN BIOPHARMACEUTICALS, INC. $120,000
- BRISTOL-MYERS SQUIBB COMPANY $80,000
- EXELIXIS, INC. $60,000
- DYNE THERAPEUTICS, INC. $40,000
- MCKESSON CORPORATION $10,000
- ALVEO TECHNOLOGIES $0
- KAILERA THERAPEUTICS INC. $0
Lobbyists named
1
- DARREN WILLCOX
Reported by year
2 years
- 2026 $1,900,000
- 2025 $3,690,000
Issues lobbied
6
Agencies and chambers lobbied
6
- HOUSE OF REPRESENTATIVES
- SENATE
- Centers For Medicare and Medicaid Services (CMS)
- Agriculture, Dept of (USDA)
- Health & Human Services, Dept of (HHS)
- Office of Management & Budget (OMB)
Recent filings
132 total
RR
KAILERA THERAPEUTICS INC.
Q2
UNITED SERVICES AUTOMOBILE ASSOCIATION (USAA)
Q2
SANOFI U.S. SERVICES, INC.
Q2
PHLOW CORP.
Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Q2
PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICAL
Q2
OTSUKA AMERICA PHARMACEUTICAL, INC.
Q2
MERCK & CO., INC.
Q2
MEDTRONIC, INC.
Q2
JUUL LABS INC
Q2
IPSEN BIOPHARMACEUTICALS, INC.
Q2
INCYTE CORPORATION
Q2
GLAXOSMITHKLINE
Q2
GILEAD SCIENCES, INC.
Q2
EXELIXIS, INC.
Q2
DYNE THERAPEUTICS, INC.
Q2
DELFI DIAGNOSTICS
Q2
CALIFORNIA LIFE SCIENCES
Q2
BRISTOL-MYERS SQUIBB COMPANY
Q2
ASTRAZENECA PHARMACEUTICALS LP